Navigation Links
Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
Date:1/26/2009

Article in Gynecologic Oncology Supports Use of Fujirebio Diagnostics'

HE4 Test with CA125 for Risk Stratification of Women with Suspected Ovarian Cancer

MALVERN, Pa., Jan. 26 /PRNewswire/ -- A pivotal clinical trial published in the January 2009 issue of the journal Gynecologic Oncology demonstrated the utility of combining Fujirebio Diagnostics' HE4 and the CA125 test as an aid in estimating the risk of epithelial ovarian cancer in premenopausal or postmenopausal women presenting with pelvic mass. The HE4 test, which is under review by the U.S. Food and Drug Administration (FDA), was reported to successfully stratify patients into high- and low-risk groups when combined with CA125.

The combination test uses the results from two simple blood tests - CA125 and HE4 - and the Risk of Ovarian Malignancy Algorithm (ROMA(TM)) to identify patients at a high risk of having ovarian cancer. CA125 is the current gold standard for monitoring patients diagnosed with ovarian cancer. The HE4 assay was recently cleared by the FDA as an aid for monitoring recurrence of epithelial ovarian cancer (EOC), the most common type of ovarian cancer. Combining the HE4 and CA125 tests may enable physicians to pre-operatively identify those patients with a high risk of malignancy.

"Research suggests that ovarian cancer patients have better outcomes and improved survival when treated by gynecologic oncologists, surgeons that are trained and specialize in the treatment of patients with EOC," said Richard G. Moore, MD, Director of Medical Education, Program in Women's Oncology at Women and Infants' Hospital, and Assistant Professor, Obstetrics and Gynecology, Brown University, Providence, R.I, and lead author of the Gynecologic Oncology paper. "Combining measurements of HE4 and CA125 helps us to identify women who are at high risk of ovarian cancer when they present with an ovarian cyst or mass. T
'/>"/>

SOURCE Fujirebio Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix
2. MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
3. Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
4. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
5. PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
6. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
7. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
8. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
9. Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD
10. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
11. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Decision Resources Group finds ... Memphis health system and hospital ... integration, with rivals Methodist Le Bonheur Healthcare and Baptist ... to coordinate patient care. In addition, a national contract ... most health plan enrollment in the Memphis ...
(Date:8/27/2014)... DALLAS , August 27, 2014 ... "Dental Equipment Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, ... 2019" published by MarketsandMarkets, the global Dental Equipment Market ... from $5,416.3 million in 2014, growing at a ... Browse 95 market data tables and 61 ...
(Date:8/27/2014)... Aug. 27, 2014 By now, if you haven,t ... living on this planet. The awareness campaign has brought this ... helped to raise over $88.5 Million (and counting) for ALS. ... some companies are starting to as well. One ... Florida , who actually works with ALS sufferers and ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2
... 31, 2011 MultiCell Technologies, Inc. (OTC Bulletin Board: ... U.S. patent 7,935,528 by the United States Patent and Trademark ... liver stem cells to treat liver disease.  Under the terms ... is the worldwide exclusive licensee of U.S. patent 7,935,528.   ...
... Biotech Ltd. (NASDAQ: SVA ), a leading provider ... Mr. Kenneth Lee as a director to the Board of ... Xianping Wang who resigned from the Board due to personal ... SAIF Partners, a leading growth capital fund focused on China ...
Cached Medicine Technology:MultiCell Technologies is Granted Stem Cell Patent 2MultiCell Technologies is Granted Stem Cell Patent 3Sinovac Appoints Kenneth Lee to Board of Directors 2
(Date:8/27/2014)... (PRWEB) August 27, 2014 Beginning in September, ... Olympic Games (DOG) as an interactive, fun way for ... be free to all K9 Dog Park Doggy Daycare clients ... two days per week. Clients will be able to ... webcams. The dogs that compete in D.O.G. will win ...
(Date:8/27/2014)... one of the leading purveyors of real and synthetic hair wigs, ... all its products, for the coming Labor Day. , People searching ... hair products in two ways: when they spend more than ... code LABOR10; while when they spend more than $299, they can ... coupon code is needed when securely checkout, there are about 50 ...
(Date:8/27/2014)... new UCLA study has shown this is definitely the case ... how to treat their prostate cancer. , UCLA researchers found ... a much more difficult time making treatment decisions, called decisional ... their care and their long-term outcomes. , The study should ... the findings to target men less likely to know a ...
(Date:8/27/2014)... Aug. 27, 2014 Stroke patients are 70 per ... medications one year later if they have a prescription ... at St. Michael,s Hospital and the Institute for Clinical ... centres, researchers determined how many Ontarians were taking their ... having a stroke. The results reveal the importance of ...
(Date:8/27/2014)... There is an ... case of pancreatic cancer, one of the most aggressive types ... patients die within five years after the diagnosis. The KIT ... mortality rate. For preclinical and clinical tests of the agents, ... from investors. This will allow for the further development of ...
Breaking Medicine News(10 mins):Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 2Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 3Health News:K9 Dog Park Announces Launch Of Daycare Olympic Games – D.O.G. 4Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 2Health News:Men who are uneducated about their prostate cancer have difficulty making good treatment choices 3Health News:A prescription for better stroke care 2Health News:Preclinical development of tumor therapeutic agent starts 2
... integrate cardiovascular activity into their lives, such as walking, would ... the study researchers surveyed nearly 18,800 women, ages 70 to ... The data show women who walked for at least 1.5 ... than those who walked less than 40 minutes per week. ...
... chemotherapy improves survival and reduces the risk of recurrence in ... not spread beyond the ovary). ,About one quarter of ... when five-year survival is 85 percent. Most doctors may prefer ... 10 patients are adequately treated by surgery alone , thus ...
... be the healthiest environment for your child at bedtime. According ... may put children at risk for leukemia. Researchers have determined ... rhythm and suppress the production of melatonin. ,As an ... DNA from oxidative damage. Once damaged, DNA may mutate and ...
... says that Man's best friend might be able to detect ... can smell odors from malignant tumors in urine samples. ... over seven months to discriminate between urine from patients with ... was then given samples of urine from six control group ...
... Patients with diabetes, Crohn's disease, bowel cancer, constipation and ... medication orally instead of using injections.Scientists in India have ... deliver // drugs to manage diseases that often require ... ,The new gel can also prevent problems caused ...
... finds a cluster of risk factors known as metabolic ... of other risk factors. // ,Metabolic syndrome ... cardiovascular and coronary heart disease. Metabolic syndrome includes looking ... pressure.Metabolic syndrome has two different definitions including one by ...
Cached Medicine News:
... wide Mini-Sub cell GT system for ... acids in agarose gels includes a ... electrodes, a 15 x 7 cm ... two casting gates, and two 1.5 ...
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
... Breeze Air Gel Dryer : Dry up to ... gels 8 10 cm without a vacuum ... drying, or no heat for controlled drying of ... dried gels. Add and remove gels at any ...
Medicine Products: